We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINC
3451
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
-15,538
Closed -$191K
DCRD
3452
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
-172,712
Closed -$1.76M
ANAC
3453
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
-1,042,812
Closed -$10.5M
CPAQ
3454
DELISTED
Counter Press Acquisition Corporation Class A Ordinary Share
CPAQ
-199,996
Closed -$2.05M
FTAA
3455
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
-1,127,130
Closed -$11.4M
FTAAW
3456
CALL
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
-200,000
Closed -$2.02M
ONEM
3457
DELISTED
1Life Healthcare
ONEM
-159,798
Closed -$2.67M
LHCG
3458
DELISTED
LHC Group LLC
LHCG
-134,842
Closed -$21.8M
NVSA
3459
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
-750,104
Closed -$7.58M
NVSAW
3460
CALL
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
-304,665
Closed -$3.08M
LGAC
3461
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
-2,742,530
Closed -$27.7M
LGACW
3462
CALL
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
-279,830
Closed -$2.83M
ACDI
3463
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
-586,681
Closed -$6.05M
ITQRW
3464
CALL
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
-49,997
Closed -$504K
ITQ
3465
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
-299,810
Closed -$3.03M
CTAQ
3466
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
-691,780
Closed -$7.08M
WQGA
3467
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
-994,265
Closed -$10.1M
WQGA.WS
3468
CALL
DELISTED
World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WQGA.WS
-222,881
Closed -$2.29M
SCOB
3469
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
-1,580,467
Closed -$16M
GSQD
3470
DELISTED
G Squared Ascend I Inc.
GSQD
-1,674,585
Closed -$16.9M
STOR
3471
DELISTED
STORE Capital Corporation
STOR
-557,060
Closed -$17.9M
BIOTW
3472
CALL
DELISTED
Biotech Acquisition Company Warrant
BIOTW
-575,000
Closed -$5.81M
SCMA
3473
DELISTED
Seaport Calibre Materials Acquisition Corp. Class A Common Stock
SCMA
-479,878
Closed -$4.93M
BIOT
3474
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
-1,012,642
Closed -$10.2M
MIT
3475
DELISTED
Mason Industrial Technology, Inc.
MIT
-2,423,479
Closed -$24.2M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.